Sarah Acaster and Siu Hing Lo recently co-authored a paper entitled ‘Burden of allergic rhinitis and impact of MP-AzeFlue from a patient perspective: a pan European patient survey’. The paper reports real-world data from 1004 allergic rhinitis patients across seven European countries. Read more here.
Development of an ambulatory assessment version of the EQ-5D-5L
Andrew Lloyd recently co-authored a paper entitled ‘How to measure fluctuating impairments in people with MS: development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study.’
The paper reports the development of an ambulatory assessment version of the EQ-5D-5L (the EQ-5D-AA), which is designed to capture within-day and day-to-day fluctuations in health. Its feasibility and face validity were established in a sample of patients with multiple sclerosis. The full text is available here.